Serum antibody fingerprinting of SARS-CoV-2 variants in infected and vaccinated subjects by label-free microarray biosensor.

IgA antibody repertoire immunoglobulins label-free biosensor rapid detection reflective phantom interface serological assay wash-free assay

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 17 10 2023
accepted: 06 02 2024
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 13 3 2024
Statut: epublish

Résumé

Both viral infection and vaccination affect the antibody repertoire of a person. Here, we demonstrate that the analysis of serum antibodies generates information not only on the virus type that caused the infection but also on the specific virus variant. We developed a rapid multiplex assay providing a fingerprint of serum antibodies against five different SARS-CoV-2 variants based on a microarray of virus antigens immobilized on the surface of a label-free reflectometric biosensor. We analyzed serum from the plasma of convalescent subjects and vaccinated volunteers and extracted individual antibody profiles of both total immunoglobulin Ig and IgA fractions. We found that Ig level profiles were strongly correlated with the specific variant of infection or vaccination and that vaccinated subjects displayed a larger quantity of total Ig and a lower fraction of IgA relative to the population of convalescent unvaccinated subjects.

Identifiants

pubmed: 38476234
doi: 10.3389/fimmu.2024.1323406
pmc: PMC10927789
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1323406

Informations de copyright

Copyright © 2024 Carzaniga, Casiraghi, Nava, Zanchetta, Inzani, Chiari, Bollati, Epis, Bandi, Lai, Zehender, Bellini and Buscaglia.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Thomas Carzaniga (T)

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy.

Luca Casiraghi (L)

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy.

Giovanni Nava (G)

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy.

Giuliano Zanchetta (G)

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy.

Tommaso Inzani (T)

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy.

Marcella Chiari (M)

Istituto di Scienze e Tecnologie Chimiche "Giulio Natta", National Research Council of Italy (SCITEC-CNR), Milano, Italy.

Valentina Bollati (V)

Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Milano, Italy.

Sara Epis (S)

Dipartimento di Bioscienze and Pediatric Clinical Research Center (CRC) 'Fondazione Romeo ed Enrica Invernizzi', Università degli Studi di Milano, Milano, Italy.

Claudio Bandi (C)

Dipartimento di Bioscienze and Pediatric Clinical Research Center (CRC) 'Fondazione Romeo ed Enrica Invernizzi', Università degli Studi di Milano, Milano, Italy.

Alessia Lai (A)

Dipartimento di Scienze Biomediche e Cliniche, Università degli Studi di Milano, Milano, Italy.

Gianguglielmo Zehender (G)

Dipartimento di Scienze Biomediche e Cliniche, Università degli Studi di Milano, Milano, Italy.

Tommaso Bellini (T)

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy.

Marco Buscaglia (M)

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy.

Classifications MeSH